Status
Conditions
Treatments
About
The purpose of this study is to assess the effectiveness of rTMS on the negative symptoms of schizophrenia in real conditions. It will also provide a regulatory framework to rTMS treatments under these conditions. 4 types of rTMS protocols are proposed, allowing to adapt to patients and their tolerances.Treatment lasts between 2 and 4 weeks, with a follow-up period of 3 months after treatment to observe relapses.To assess the evolution of negative symptoms between baseline and the end of treatment, investigators use SANS (Scale for the Assessment of Negative Symptoms).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Negative PANSS score ⩾21, positive PANSS score ⩽24
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
124 participants in 4 patient groups
Loading...
Central trial contact
Youcef Bencherif
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal